Hernia Reduction Prior to Scheduled TIF Completion
- Conditions
- Fundoplication
- Interventions
- Device: EsophyX ZR transoral device
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2021-02-10
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 14
- Registration Number
- NCT03280121
- Locations
- 🇺🇸
Northern Nevada Medical Center, Sparks, Nevada, United States
🇺🇸Aspirus Iron River Hospital, Iron River, Michigan, United States
🇺🇸Elkhart General Hospital, Elkhart, Indiana, United States
The EndoGastric Solutions TEMPO Trial
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Drug: PPIDevice: EsophyX System with SerosaFuse fasteners
- First Posted Date
- 2012-07-24
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 65
- Registration Number
- NCT01647958
- Locations
- 🇺🇸
EndoGastric Solutions, Redmond, Washington, United States
Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study
- Conditions
- Gastroesophageal Reflux Disease (GERD)
- Interventions
- Device: Transoral Incisionless Fundoplication
- First Posted Date
- 2011-04-04
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 110
- Registration Number
- NCT01327963
- Locations
- 🇺🇸
Livingston Hospital and Healthcare Services, Inc. CAH, Salem, Kentucky, United States
🇺🇸Munroe Regional Medical Center, Ocala, Florida, United States
Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study
- Conditions
- Hiatal HerniaGastroesophageal Reflux Disease
- Interventions
- Other: Sham placebo procedureDevice: TIF Transoral Fundoplication
- First Posted Date
- 2010-06-04
- Last Posted Date
- 2021-12-03
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 129
- Registration Number
- NCT01136980
- Locations
- 🇺🇸
Oregon Health and Science University, Portland, Oregon, United States
🇺🇸Reston Surgical Associates, Reston, Virginia, United States
🇺🇸Cedars Sinai Medical Center, Los Angeles, California, United States
Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
- Conditions
- Hiatal HerniaGastroesophageal Reflux Disease
- Interventions
- Procedure: TIF Procedure
- First Posted Date
- 2010-05-06
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 278
- Registration Number
- NCT01118585
- Locations
- 🇺🇸
The Surgeons Group of Baton Rouge, Baton Rouge, Louisiana, United States
🇺🇸Swedish Medical Center and SurgOne P.C., Englewood, Colorado, United States
🇺🇸Master Center for Minimally Invasive Surgery, Southlake, Texas, United States
Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)
- Conditions
- Hiatal HerniaGastroesophageal Reflux Disease
- Interventions
- Procedure: Transoral Incisionless Fundoplication (TIF)
- First Posted Date
- 2010-04-27
- Last Posted Date
- 2019-03-06
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 60
- Registration Number
- NCT01110811
- Locations
- 🇫🇷
University of Nantes Hospital, Nantes, France
🇸🇪Karolinska University, Ersta Hospital, Stockholm, Sweden
🇧🇪University Hospitals Leuven, Leuven, Belgium
StomaphyX Versus Sham for Revisional Surgery in Post-Roux-en-Y Patients to Reduce Regained Weight
- Conditions
- Obesity
- Interventions
- Device: StomaphyXProcedure: Sham procedure
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2020-11-23
- Lead Sponsor
- EndoGastric Solutions
- Target Recruit Count
- 112
- Registration Number
- NCT00939055
- Locations
- 🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States